Health - Resources and discussion for everything health-related

2399 readers

239 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 2 years ago

MODERATORS

[email protected]

152

Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs (www.nbcnews.com)

submitted 2 months ago* (last edited 2 months ago) by [email protected] to c/[email protected]

35 comments fedilink hide all child comments

The chief executive of the drugmaker Novo Nordisk, Lars Fruergaard Jørgensen, is scheduled to face tough questions Tuesday on Capitol Hill about the high costs of the company’s widely popular weight-loss drugs.

Jørgensen will appear before the Senate Committee on Health, Education, Labor and Pensions during a livestreamed hearing Tuesday starting at 10 a.m. ET.

The head of the committee, Sen. Bernie Sanders, I-Vt., has been vocal about his frustrations over how much Novo Nordisk charges Americans for both Ozempic (used to treat type 2 diabetes) and Wegovy (approved for weight loss).

"In general, we pay by far the highest prices in the world for prescription drugs. Same exact medicine sold in Canada, Europe is a fraction of what it is in the United States," Sanders said in an interview Monday. "The result of that is that hundreds of thousands of people in this country who desperately need this product will not be able to afford it."

you are viewing a single comment's thread
view the rest of the comments

[–] [email protected] 6 points 2 months ago

That's just crabs in a bucket. There's no reason we need to only look at one drug at a time, congress could make sweeping drug price reforms any time it wants. Fighting over which single thing to look at first only allows politicians to stall because "no one can decide on what to do."